Equine Healthcare Market Size, Share, Growth Analysis, By Product Type(Vaccines, Pharmaceuticals), By Indication(Musculoskeletal Disorders, Internal Medicine) - Industry Forecast 2024-2031

Report ID: SQMIG35G2223 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 71 | Figures: 70

Share your requirements to help us to customize the report.

I acknowledge that I have read the Privacy Policy

Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

License Type Top market research company in USA

File Type

Analyst Support

$5,300

BUY NOW GET FREE SAMPLE

FAQs

Equine Healthcare Market size was valued at USD 2.87 billion in 2022 and is poised to grow from USD 3.36 billion in 2023 to USD 11.70 billion by 2031, growing at a CAGR of 16.9% in the forecast period (2024-2031).

The competitive landscape of the equine healthcare market is characterized by the presence of several key players focusing on delivering a wide array of products and services catering to the diverse needs of horse owners, trainers, and veterinary professionals. Companies are actively engaged in research and development to innovate new treatment methods, medications, and diagnostic tools to address various equine health concerns. Established pharmaceutical companies, veterinary clinics, and specialized equine healthcare providers vie for market share by emphasizing the quality, effectiveness, and safety of their offerings. Collaboration with veterinarians, universities, and research institutions is common for developing advanced equine healthcare solutions. 'Zoetis Inc.', 'Merck Animal Health', 'Boehringer Ingelheim International GmbH', 'Elanco Animal Health', 'Bayer AG', 'Ceva Santé Animale', 'Virbac', 'Dechra Pharmaceuticals PLC', 'IDEXX Laboratories, Inc.', 'Vetoquinol S.A.', 'Norbrook Laboratories Limited', 'EQUINE PRODUCTS UK LTD', 'KRKA', 'HIPRA', 'Luitpold Pharmaceuticals, Inc.'

The increasing awareness and concern for the health and well-being of equines, especially in high-performance sectors like racing, sports, and leisure, are driving the demand for advanced healthcare solutions.

Personalized Healthcare Solutions: The equine healthcare market is witnessing a trend towards personalized treatment plans and solutions. Advanced diagnostics, genetic testing, and tailored treatment regimens are becoming more common to address specific health needs of individual horses.

In 2022, North America asserted its dominance by capturing a significant share of more than 35.0%. The region's strong hold is backed by notable statistics, as reported by the FAO, indicating around 10.56 million horses in the U.S. in 2021, with approximately 10.96 million horses across North America. The prevalence of horse farms and the bustling annual horse racing calendar contribute to the region's market share. The U.S. boasts around 300 racetracks and hosts nearly 33,567 horse races annually. The import of approximately 18,865 horses into the U.S. in 2021 further fuels the demand for equine healthcare in North America.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Equine Healthcare Market Size, Share, Growth Analysis, By Product Type(Vaccines, Pharmaceuticals), By Indication(Musculoskeletal Disorders, Internal Medicine) - Industry Forecast 2024-2031

Share your requirements to help us to customize the report.

Confidentiality

FAQs

What is the market size of Equine Healthcare Market?

Who are the key vendors in the Equine Healthcare Market?

What is the key driver of Equine Healthcare Market?

What is the key market trend for Equine Healthcare Market?

Which region accounted for the largest share in Equine Healthcare Market?

Related Reports

Feedback From Our Clients

$5,300